Joint Formulary & PAD

Exenatide - Diabetes Mellitus

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Not Specified
Associated Icons :
Restrictions / Comments :

PAD Profile

ChemicalSubstance :
Exenatide
Indication :
Diabetes Mellitus
Group Name :
GLP-1s
Keywords :
GLP-1 with insulin; diabetes guidelines
Brand Names Include :
Bydureon
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
3

Committee Recommendations (1)

In February 2018, once-weekly exenatide was agreed as GREEN by the former Surrey & Sussex Prescribing Committee.

At the October 2025 APC, it was agreed to remove any recommendation of a preferred GLP-1 mimetic.

Other Indications

Below are listed other indications that Exenatide is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Diabetes Mellitus.